How I do it: The Neuro-Ophthalmological Assessment in Parkinson's Disease
- PMID: 30958314
- PMCID: PMC6597980
- DOI: 10.3233/JPD-181523
How I do it: The Neuro-Ophthalmological Assessment in Parkinson's Disease
Abstract
Visual disorders like double vision, dry eyes, and visual field deficits are common but frequently missed in Parkinson's disease. Here, we aim to increase awareness for these visual disorders in Parkinson patients by discussing several common problems that can be easily diagnosed using comprehensive history taking and a basic neuro-ophthalmological examination. We offer practical guidance for the patient interview and physical exam that can facilitate a timelier recognition of visual disorders. Such recognition has immediate therapeutic relevance, because Parkinson patients are strongly dependent on an adequate vision, for example to optimally benefit from visual cueing strategies.
Keywords: Neuro-ophthalmology; parkinson’s disease; vision.
Similar articles
-
The bedside and office neuro-ophthalmology examination.Semin Neurol. 2003 Mar;23(1):63-76. doi: 10.1055/s-2003-40753. Semin Neurol. 2003. PMID: 12870107 Review.
-
The neuro-ophthalmological examination.Handb Clin Neurol. 2011;102:71-94. doi: 10.1016/B978-0-444-52903-9.00009-1. Handb Clin Neurol. 2011. PMID: 21601063 Review.
-
Ophthalmological and electrophysiological features of Parkinson's disease.Klin Oczna. 2010;112(7-9):247-52. Klin Oczna. 2010. PMID: 21117366 Review.
-
[Perimetry in Neuro-ophthalmological Function Diagnostics: Indication - Methods - Topodiagnostic Aspects].Klin Monbl Augenheilkd. 2018 Nov;235(11):1218-1228. doi: 10.1055/a-0668-5971. Epub 2018 Oct 16. Klin Monbl Augenheilkd. 2018. PMID: 30326540 Review. German.
-
The neuro-ophthalmic examination.Neurol Clin. 1983 Nov;1(4):807-30. Neurol Clin. 1983. PMID: 6680174
Cited by
-
Parkinson's Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization.Diagnostics (Basel). 2020 May 25;10(5):339. doi: 10.3390/diagnostics10050339. Diagnostics (Basel). 2020. PMID: 32466249 Free PMC article. Review.
-
Applicability of optical coherence tomography angiography (OCTA) imaging in Parkinson's disease.Sci Rep. 2021 Mar 9;11(1):5520. doi: 10.1038/s41598-021-84862-x. Sci Rep. 2021. PMID: 33750844 Free PMC article.
-
The Role of Architecture and Design in the Management of Parkinson's Disease: A Systematic Review.J Parkinsons Dis. 2020;10(4):1301-1314. doi: 10.3233/JPD-202035. J Parkinsons Dis. 2020. PMID: 32804100 Free PMC article.
-
Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up.Diagnostics (Basel). 2021 Dec 17;11(12):2380. doi: 10.3390/diagnostics11122380. Diagnostics (Basel). 2021. PMID: 34943619 Free PMC article.
-
Artificial intelligence extension of the OSCAR-IB criteria.Ann Clin Transl Neurol. 2021 Jul;8(7):1528-1542. doi: 10.1002/acn3.51320. Epub 2021 May 19. Ann Clin Transl Neurol. 2021. PMID: 34008926 Free PMC article. Review.
References
-
- Ekker MS, Janssen S, Seppi K, Poewe W, de Vries NM, Theelen T, Nonnekes J, Bloem BR (2017) Ocular and visual disorders in Parkinson’s disease: Common but frequently overlooked. Parkinsonism Relat Disord 40, 1–10. - PubMed
-
- Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2009) The retina in Parkinson’s disease. Brain 132, 1128–1145. - PubMed
-
- Nguyen-Legros J (1988) Functional neuroarchitecture of the retina: Hypothesis on the dysfunction of retinal dopamin-ergic circuitry in Parkinson’s disease. Surg Radiol Anat 10, 137–144. - PubMed
-
- Davidsdottir S, Cronin-Golomb A, Lee A (2005) Visual and spatial symptoms in Parkinson’s disease. Vision Res 45, 1285–1296. - PubMed
-
- Guo L, Normando EM, Shah PA, De Groef L, Cordeiro MF (2018) Oculo-visual abnormalities in Parkinson’s disease: Possible value as biomarkers. Mov Disord 33, 1390–1406. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical